1. Home
  2. Analysis
  3. Amifostine
  4. Restoril

Amifostine and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amifostine (amifostine) and Restoril (temazepam). Common drug interactions include abdominal pain among females.

The phase IV clinical study analyzes what interactions people have when they take Amifostine and Restoril. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Amifostine?

Amifostine has active ingredients of amifostine. eHealthMe is studying from 425 Amifostine users. Check the latest studies of Amifostine.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.

On Jul, 15, 2026

20 people who take Amifostine and Restoril together, and have interactions are studied.

Amifostine and Restoril drug interactions.

What are the common drug interactions of Amifostine and Restoril, by gender? *:

female:

  1. Abdominal pain
  2. Accident at work
  3. Bone density decreased
  4. Bone disorder
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  6. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  7. Colitis (inflammation of colon)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  10. Epicondylitis (tennis elbow)

male:

n/a

What are the common drug interactions of Amifostine and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Accident at work
  3. Bone density decreased
  4. Bone disorder
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  6. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  7. Colitis (inflammation of colon)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  10. Epicondylitis (tennis elbow)

60+:

n/a

What are the existing conditions these people have? *

  1. Ovarian Cancer (cancer of ovary): 20 people, 100.00%
  2. Neoplasm Malignant (cancer tumour): 20 people, 100.00%
  3. Migraine (headache): 20 people, 100.00%
  4. Hot Flush (sudden feelings of heat): 20 people, 100.00%
  5. Discomfort: 20 people, 100.00%
  6. Breast Cancer Metastatic: 20 people, 100.00%
  7. Breast Cancer: 20 people, 100.00%
  8. Granulocyte Count Decreased: 19 people, 95.00%

* Approximation only. Some reports may have incomplete information.

Do you take Amifostine and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amifostine and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amifostine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amifostine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amifostine and temazepam (the active ingredients of Amifostine and Restoril, respectively), and Amifostine and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.